Host Immune Modulation: A Strategy to Enhance the Efficacy of Antifungal Therapy

Fungal infections present a major global health challenge, particularly among immunocompromised individuals due to the development of antifungal drug resistance, demanding innovative therapeutic strategies for treatment. One promising approach is host immune modulation, which strengthens the body's innate and adaptive immune responses to enhance fungal clearance and improve treatment outcomes. This strategy encompasses various techniques, including cytokine therapy, immune checkpoint modulation, vaccination, adoptive cell therapy, and personalized treatments, all aimed at effectively reinforcing the immune system’s ability to combat fungal pathogens. Additionally, cutting-edge approaches such as metabolic reprogramming, epigenetic modulation, microbiome-targeted therapies, and nanotechnology-driven immune modulation are emerging as powerful tools to fine-tune host defences. Targeting host pathways through autophagy and cellular stress responses further enhances the body’s ability to resist fungal infections. These host-directed therapies not only reduce reliance on conventional antifungal drugs but also help curb drug resistance by promoting long-lasting and pathogen-specific immunity. Understanding the intricate interplay between the immune system and fungal pathogens is crucial for developing precise, durable, and patient-centric treatments. By leveraging these advanced therapeutic strategies, researchers can revolutionize antifungal therapy, offering more effective, sustainable, and personalized interventions, ultimately reducing the burden of fungal diseases and improving patient survival worldwide.